193 related articles for article (PubMed ID: 31200059)
1. Treatment of Critical Limb Ischemia by pIRES/VEGF165/HGF Administration.
Barć P; Antkiewicz M; Śliwa B; Baczyńska D; Witkiewicz W; Skóra JP
Ann Vasc Surg; 2019 Oct; 60():346-354. PubMed ID: 31200059
[TBL] [Abstract][Full Text] [Related]
2. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
3. Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus.
Barć P; Antkiewicz M; Śliwa B; Frączkowska K; Guziński M; Dawiskiba T; Małodobra-Mazur M; Witkiewicz W; Kupczyńska D; Strzelec B; Janczak D; Skóra JP
J Cardiovasc Transl Res; 2021 Jun; 14(3):409-415. PubMed ID: 32875492
[TBL] [Abstract][Full Text] [Related]
4. Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach.
Chiriano J; Bianchi C; Teruya TH; Mills B; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2010 Nov; 24(8):1110-6. PubMed ID: 21035703
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.
Powell RJ; Goodney P; Mendelsohn FO; Moen EK; Annex BH;
J Vasc Surg; 2010 Dec; 52(6):1525-30. PubMed ID: 21146749
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of ulcer healing and amputation-free survival in patients with critical limb ischemia.
Furuyama T; Onohara T; Yamashita S; Yoshiga R; Yoshiya K; Inoue K; Morisaki K; Kyuragi R; Matsumoto T; Maehara Y
Vascular; 2018 Dec; 26(6):626-633. PubMed ID: 30003829
[TBL] [Abstract][Full Text] [Related]
7. Early ABI Testing May Decrease Risk of Amputation for Patients With Lower Extremity Ulcers.
Aguirre A; Sharma K; Arora A; Humphries MD
Ann Vasc Surg; 2022 Feb; 79():65-71. PubMed ID: 34656726
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of autologous bone marrow mononuclear cells with VEGF gene improves diabetic critical limb ischaemia.
Skóra J; Barć P; Pupka A; Dawiskiba T; Korta K; Albert M; Szyber P
Endokrynol Pol; 2013; 64(2):129-38. PubMed ID: 23653276
[TBL] [Abstract][Full Text] [Related]
9. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
[TBL] [Abstract][Full Text] [Related]
10. Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss.
Vallabhaneni R; Kalbaugh CA; Kouri A; Farber MA; Marston WA
J Vasc Surg; 2016 Jan; 63(1):105-12. PubMed ID: 26412436
[TBL] [Abstract][Full Text] [Related]
11. Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication.
Deev R; Plaksa I; Bozo I; Mzhavanadze N; Suchkov I; Chervyakov Y; Staroverov I; Kalinin R; Isaev A
Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):237-246. PubMed ID: 29996720
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia.
Shyu KG; Chang H; Wang BW; Kuan P
Am J Med; 2003 Feb; 114(2):85-92. PubMed ID: 12586226
[TBL] [Abstract][Full Text] [Related]
13. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.
Morishita R; Aoki M; Hashiya N; Makino H; Yamasaki K; Azuma J; Sawa Y; Matsuda H; Kaneda Y; Ogihara T
Hypertension; 2004 Aug; 44(2):203-9. PubMed ID: 15238569
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.
Iida O; Soga Y; Hirano K; Kawasaki D; Suzuki K; Miyashita Y; Terashi H; Uematsu M
J Vasc Surg; 2012 Feb; 55(2):363-370.e5. PubMed ID: 22051875
[TBL] [Abstract][Full Text] [Related]
16. Cumulative Number of Treatment Interventions Predicts Health-Related Quality of Life in Patients with Critical Limb Ischemia.
Corriere MA; Goldman MP; Barnard R; Saldana S; Stafford JM; Easterling D; Ip EH; Burke GL
Ann Vasc Surg; 2017 Oct; 44():41-47. PubMed ID: 28479452
[TBL] [Abstract][Full Text] [Related]
17. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.
Okazaki J; Matsuda D; Tanaka K; Ishida M; Kuma S; Morisaki K; Furuyama T; Maehara Y
J Vasc Surg; 2018 Mar; 67(3):817-825. PubMed ID: 29032905
[TBL] [Abstract][Full Text] [Related]
18. Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.
Kum S; Tan YK; Schreve MA; Ferraresi R; Varcoe RL; Schmidt A; Scheinert D; Mustapha JA; Lim DM; Ho D; Tang TY; Alexandrescu VA; Mutirangura P
J Endovasc Ther; 2017 Oct; 24(5):619-626. PubMed ID: 28697694
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Care for Critical Limb Ischemia: Current Gaps and Opportunities for Improvement.
Armstrong EJ; Alam S; Henao S; Lee AC; DeRubertis BG; Montero-Baker M; Mena C; Cua B; Palena LM; Kovach R; Chandra V; AlMahameed A; Walker CM
J Endovasc Ther; 2019 Apr; 26(2):199-212. PubMed ID: 30706755
[TBL] [Abstract][Full Text] [Related]
20. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia.
Singh GD; Armstrong EJ; Waldo SW; Alvandi B; Brinza E; Hildebrand J; Amsterdam EA; Humphries MD; Laird JR
Vasc Med; 2017 Jun; 22(3):210-217. PubMed ID: 28466753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
